Currax Pharmaceuticals has a total of 74 patents globally, out of which 50 have been granted. Of these 74 patents, more than 64% patents are active. United States of America is where Currax Pharmaceuticals has filed the maximum number of patents, followed by Europe and Austria. Parallelly, United States of
Hospira has a total of 1056 patents globally, out of which 474 have been granted. Of these 1056 patents, more than 23% patents are active. United States of America is where Hospira has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems
IntraBio has a total of 279 patents globally, out of which 98 have been granted. Of these 279 patents, more than 87% patents are active. The United States of America is where IntraBio has filed the maximum number of patents, followed by Europe and Korea (South). Parallelly, United Kingdom seems
AlzeCure Pharma has a total of 87 patents globally, out of which 23 have been granted. Of these 87 patents, more than 73% patents are active. The United States of America is where AlzeCure Pharma has filed the maximum number of patents, followed by China. Parallelly, United Kingdom seems to
1st Biotherapeutics has a total of 74 patents globally, out of which 11 have been granted. Of these 74 patents, more than 83% patents are active. The United States of America is where 1st Biotherapeutics has filed the maximum number of patents, followed by Europe. Parallelly, United States of America
Calithera Biosciences has a total of 476 patents globally, out of which 189 have been granted. Of these 476 patents, more than 64% patents are active. The United States of America is where Calithera Biosciences has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States
Pitney Pharmaceuticals has a total of 75 patents globally, out of which 78 have been granted. Of these 75 patents, more than 59% patents are active. New Zealand is where Pitney Pharmaceuticals has filed the maximum number of patents. Parallelly, Australia seems to be the main focused R&D centre and
Adastra Pharmaceuticals has a total of 60 patents globally, out of which 7 have been granted. Of these 60 patents, more than 21% patents are active. Europe (EPO) is where Adastra Pharmaceuticals has filed the maximum number of patents, followed by the USA and Canada. Parallelly, The United States of
Aptose Biosciences has a total of 161 patents globally, out of which 69 have been granted. Of these 161 patents, more than 37% patents are active. The United States of America is where Aptose Biosciences has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, The
Swedish Orphan Biovitrum has a total of 1852 patents globally, out of which 822 have been granted. Of these 1852 patents, more than 46% patents are active. The USA is where Swedish Orphan Biovitrum has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, Sweden seems
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.